the beta-blocker heart attack trial ( bhat ) was a multicentered , double-blind , randomized , placebo-controlled clinical trial designed to test the efficacy of long-term therapy with propranolol given to survivors of an acute myocardial infarction ( mi ) .
C0027051
heart attack
C0033497
propranolol